Perspective Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jun '22 Jun 30, 2022
Cash & Equivalents	53.97	30.63	61.58	9.24	20.99	55.89
Short-Term Investments	216.96	114.11	165.34	-	22.76	-
Cash & Short-Term Investments	270.93	144.74	226.92	9.24	43.76	55.89
Cash Growth	27.98%	-36.22%	2356.33%	-78.89%	-21.71%	-12.44%
Accounts Receivable	0.06	0.01	0.12	1.17	1.36	1.61
Other Receivables	-	-	-	-	6.11	-
Total Trade Receivables	0.06	0.01	0.12	1.17	7.47	1.61
Inventory	-	-	-	-	-	1.4
Other Current Assets	4.37	3.65	4.13	6.43	1.99	0.44
Total Current Assets	275.35	148.39	231.16	16.84	53.22	59.33
Net Property, Plant & Equipment	94.93	78.1	59.54	6.32	0.37	2.49
Other Intangible Assets	40	40	50	50	-	-
Goodwill	-	-	-	24.06	-	-
Other Long-Term Assets	0.49	0.49	0.41	0.67	4.51	2.62
Total Assets	410.77	266.97	341.1	97.89	58.09	64.44
Accounts Payable	26.49	20.51	10.34	6.91	1.54	0.97
Accrued Expenses	3.88	7.49	5.48	3.59	1.3	1.03
Current Portion of Long-Term Debt	0.06	0.06	0.05	0.05	-	-
Current Portion of Leases	1.07	0.62	0.96	0.05	-	0.27
Unearned Revenue	-	-	1.4	-	-	-
Other Current Liabilities	-	-	-	5.07	0.28	-
Total Current Liabilities	31.49	28.68	18.23	15.66	3.12	2.27
Long-Term Debt	1.55	1.57	1.63	1.68	-	-
Long-Term Leases	1.55	1.01	1.43	0.78	-	0.26
Other Long-Term Liabilities	28.74	28.69	29.15	4.59	0.33	0.64
Total Long-Term Liabilities	31.85	31.26	32.2	7.05	0.33	0.9
Total Liabilities	63.33	59.94	50.43	22.71	3.45	3.16
Common Stock	0.11	0.07	0.07	0.03	0.14	0.14
Additional Paid-in Capital	708.58	541.69	522.37	227.59	160.43	159.73
Accumulated Other Comprehensive Income	-0.23	0.11	-0.05	-	-	-
Retained Earnings	-361.03	-334.84	-231.72	-152.44	-105.93	-98.6
Shareholders' Equity	347.44	207.03	290.67	75.18	54.64	61.28
Total Liabilities & Equity	410.77	266.97	341.1	97.89	58.09	64.44
Total Debt	4.23	3.25	4.06	2.55	0	0.52
Net Cash (Debt)	266.7	141.48	222.85	6.69	43.76	55.37
Net Cash Growth	88.50%	-36.51%	3232.64%	-84.72%	-20.97%	-12.19%
Net Cash Per Share	3.27	1.92	3.46	0.25	3.08	3.90
Book Value	347.44	207.03	290.67	75.18	54.64	61.28
Book Value Per Share	4.26	2.80	4.51	2.81	3.85	4.32
Tangible Book Value	307.44	167.03	240.67	1.12	54.64	61.28
Tangible Book Value Per Share	3.77	2.26	3.74	0.04	3.85	4.32

Updated May 11, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q